Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2012 15.60M
June 30, 2012 15.60M
March 31, 2012 15.60M
December 31, 2011 15.59M
September 30, 2011 15.49M
June 30, 2011 15.58M
March 31, 2011 15.58M
December 31, 2010 15.57M
September 30, 2010 15.57M
June 30, 2010 15.56M
March 31, 2010 15.56M
December 31, 2009 15.55M
September 30, 2009 15.35M
June 30, 2009 15.24M
March 31, 2009 15.24M
December 31, 2008 15.33M
September 30, 2008
June 30, 2008 15.33M
March 31, 2008 15.33M
December 31, 2007 15.23M
September 30, 2007 15.23M
June 30, 2007 15.23M
March 31, 2007 15.33M
December 31, 2006 15.33M
September 30, 2006 15.23M
Date Value
June 30, 2006 15.33M
March 31, 2006 15.30M
December 31, 2005 15.33M
September 30, 2005 15.30M
June 30, 2005 15.20M
March 31, 2005 15.20M
December 31, 2004 15.30M
September 30, 2004 15.29M
June 30, 2004 10.21M
March 31, 2004 10.10M
December 31, 2003 10.10M
September 30, 2003 10.10M
June 30, 2003 10.10M
March 31, 2003 10.10M
December 31, 2002 10.20M
September 30, 2002 10.07M
June 30, 2002 10.05M
March 31, 2002 10.04M
December 31, 2001 9.884M
September 30, 2001 9.862M
June 30, 2001 9.808M
March 31, 2001 9.808M
December 31, 2000 9.798M
September 30, 2000 9.598M
June 30, 2000 9.493M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 78.87M
Neogen Corp. 217.70M
QuidelOrtho Corp. 68.30M
Aspira Women's Health, Inc. 46.63M
VolitionRX Ltd. 12.04M